SPECGX LLC FDA Approval ANDA 087846

ANDA 087846

SPECGX LLC

FDA Drug Application

Application #087846

Documents

Letter2013-03-13
Label2013-03-12
Label2014-09-05
Other Important Information from FDA2007-05-09
Medication Guide2018-11-08

Application Sponsors

ANDA 087846SPECGX LLC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL50MG0TOFRANILIMIPRAMINE HYDROCHLORIDE
002TABLET;ORAL10MG0IMIPRAMINE HYDROCHLORIDEIMIPRAMINE HYDROCHLORIDE
003TABLET;ORAL25MG0IMIPRAMINE HYDROCHLORIDEIMIPRAMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1984-05-22
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1986-07-25
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1986-07-25
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1986-10-23
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1992-12-14
LABELING; LabelingSUPPL10AP1993-02-02
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1992-12-14
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1993-02-25
LABELING; LabelingSUPPL13AP1994-12-20
LABELING; LabelingSUPPL15AP1998-09-01
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1997-09-26
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1999-07-15
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2000-09-14
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2000-09-14
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2002-06-12
LABELING; LabelingSUPPL21AP2004-08-31
LABELING; LabelingSUPPL22AP2005-06-09
LABELING; LabelingSUPPL23AP2005-09-12
LABELING; LabelingSUPPL25AP2007-06-25
LABELING; LabelingSUPPL26AP2007-09-27
LABELING; LabelingSUPPL28AP2014-07-17STANDARD
LABELING; LabelingSUPPL29AP2017-06-29STANDARD

Submissions Property Types

SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL11Null0
SUPPL12Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL28Null7
SUPPL29Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87846
            [companyName] => SPECGX LLC
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/087846s028,087844s027,087845s027lbl.pdf#page=3"]
            [products] => [{"drugName":"IMIPRAMINE HYDROCHLORIDE","activeIngredients":"IMIPRAMINE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"IMIPRAMINE HYDROCHLORIDE","activeIngredients":"IMIPRAMINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TOFRANIL","activeIngredients":"IMIPRAMINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => [{"actionDate":"07\/17\/2014","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/087846s028,087844s027,087845s027lbl.pdf\"}]","notes":""},{"actionDate":"09\/27\/2007","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/087844s025,087845s025,087846s026pi.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"IMIPRAMINE HYDROCHLORIDE","submission":"IMIPRAMINE HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"IMIPRAMINE HYDROCHLORIDE","submission":"IMIPRAMINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"TOFRANIL","submission":"IMIPRAMINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2014-07-17
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.